Short Interest in Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) Expands By 150.0%

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) saw a significant increase in short interest in April. As of April 15th, there was short interest totalling 500 shares, an increase of 150.0% from the March 31st total of 200 shares. Based on an average trading volume of 3,000 shares, the days-to-cover ratio is currently 0.2 days.

Lixte Biotechnology Price Performance

Shares of NASDAQ:LIXTW remained flat at $0.05 during trading on Friday. The firm has a 50-day moving average price of $0.07 and a 200-day moving average price of $0.07. Lixte Biotechnology has a 52 week low of $0.03 and a 52 week high of $0.14.

About Lixte Biotechnology

Lixte Biotechnology Holdings, Inc operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.